Paper41258010
Dual role of ROS-dependent anti-cancer activity and photocatalytic degradation of graphene oxide against MCF-7 breast cancer cells and organic dye.
Chelliah CK and 12 others. Sci Rep, 2025. Cited by 1 paper, by iCite. Retracted.
Cite this record
ConductScience Library. Dual role of ROS-dependent anti-cancer activity and photocatalytic degradation of graphene oxide against MCF-7 breast cancer cells and organic dye. Papers, record 41258010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41258010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dual role of ROS-dependent anti-cancer activity and photocatalytic degradation of graphene oxide against MCF-7 breast cancer cells and organic dye.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graphite | Major topic |
| Reactive Oxygen Species | Major topic |
| Antineoplastic Agents | Major topic |
| Breast Neoplasms | Major topic |
| Coloring Agents | Major topic |
| Humans | |
| MCF-7 Cells | |
| Apoptosis | |
| Female | |
| Catalysis | |
| Rhodamines |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 42717226 | Retraction Note: Dual role of ROS-dependent anti-cancer activity and photocatalytic degradation of graphene oxide against MCF-7 breast cancer cells and organic dye. | https://conductscience.org/library/papers/42717226 |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38521844 | Diverse functions of cytochrome c in cell death and disease. | Cell Death Differ | 2024 | https://conductscience.org/library/papers/38521844 | PubMed |
| 2 | 29908495 | Phytol shows anti-angiogenic activity and induces apoptosis in A549 cells by depolarizing the mitochondrial membrane potential. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29908495 | PubMed |
| 3 | 38378052 | Graphene oxide as an emerging sole adsorbent and photocatalyst: Chemistry of synthesis and tailoring properties for removal of emerging contaminants. | Chemosphere | 2024 | https://conductscience.org/library/papers/38378052 | PubMed |
| 4 | 36012549 | The Reduced Graphene Oxide (rGO) Induces Apoptosis, Autophagy and Cell Cycle Arrest in Breast Cancer Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012549 | PubMed |
| 5 | 36641122 | Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis. | J Control Release | 2023 | https://conductscience.org/library/papers/36641122 | PubMed |
| 6 | 39720083 | Progress in photocatalytic degradation of industrial organic dye by utilising the silver doped titanium dioxide nanocomposite. | Heliyon | 2024 | https://conductscience.org/library/papers/39720083 | PubMed |
| 7 | 35478542 | Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer. | RSC Adv | 2021 | https://conductscience.org/library/papers/35478542 | PubMed |
| 8 | 21962852 | Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide. | Colloids Surf B Biointerfaces | 2012 | https://conductscience.org/library/papers/21962852 | PubMed |
| 9 | 26349970 | Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. | Biomed Pharmacother | 2015 | https://conductscience.org/library/papers/26349970 | PubMed |
| 10 | 21851105 | Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. | ACS Nano | 2011 | https://conductscience.org/library/papers/21851105 | PubMed |
| 11 | 39502215 | Bioactivity of biogenic silver/silver chloride nanoparticles from Maranta arundinacea rhizome extract: Antibacterial and antioxidant properties with anticancer potential against Ehrlich ascites carcinoma and human breast cancer cell lines. | Heliyon | 2024 | https://conductscience.org/library/papers/39502215 | PubMed |
| 12 | 31115493 | Mitochondrial electron transport chain, ROS generation and uncoupling (Review). | Int J Mol Med | 2019 | https://conductscience.org/library/papers/31115493 | PubMed |
| 13 | 33157326 | Uptake of silver, gold, and hybrids silver-iron, gold-iron and silver-gold aminolevulinic acid nanoparticles by MCF-7 breast cancer cells. | Photodiagnosis Photodyn Ther | 2020 | https://conductscience.org/library/papers/33157326 | PubMed |
| 14 | 39154682 | Graphene oxide nanoribbons conjugated with 1, 2-distearoyl-sn-glycero-3 phosphoethanolamine-poly (ethylene glycol)-transferrin enhanced targeted delivery and cytotoxicity of raloxifene against breast cancer. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/39154682 | PubMed |
| 15 | 28704918 | Anticancer activity of graphene oxide-reduced graphene oxide-silver nanoparticle composites. | J Colloid Interface Sci | 2017 | https://conductscience.org/library/papers/28704918 | PubMed |
| 16 | 36594058 | Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line. | Iran J Basic Med Sci | 2023 | https://conductscience.org/library/papers/36594058 | PubMed |
| 17 | 36906140 | Cellular uptake of biotransformed graphene oxide into lung cells. | Chem Biol Interact | 2023 | https://conductscience.org/library/papers/36906140 | PubMed |
| 18 | 29165994 | From Graphene Oxide to Reduced Graphene Oxide: Impact on the Physiochemical and Mechanical Properties of Graphene-Cement Composites. | ACS Appl Mater Interfaces | 2017 | https://conductscience.org/library/papers/29165994 | PubMed |
| 19 | 24789533 | Harnessing the chemistry of graphene oxide. | Chem Soc Rev | 2014 | https://conductscience.org/library/papers/24789533 | PubMed |
| 20 | 37820908 | Chitosan biopolymer functionalized with graphene oxide and titanium dioxide with Escin metallic nanocomposites for anticancer potential against colon cancer. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/37820908 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42412309 | Green Fabrication and Characterization of Copper Oxide Nanoparticles Using C. Gigantea Leaf Extract and Their ROS-Mediated Anticancer Activity Against A549 Lung Cancer Cells. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42412309 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CASP9 | 842 | PubTator's text mining | https://conductscience.org/library/genes/842 | NCBI Gene |
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41258010
GET https://conductscience.org/api/papers/v1/41258010/references?page=2